Transcription of a human dopamine D5 pseudogene.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 1958184)

Published in Biochem Biophys Res Commun on November 27, 1991

Authors

T Nguyen1, R Sunahara, A Marchese, H H Van Tol, P Seeman, B F O'Dowd

Author Affiliations

1: Addiction Research Foundation, Toronto, Ont., Canada.

Articles by these authors

The membrane actions of anesthetics and tranquilizers. Pharmacol Rev (1972) 11.00

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature (1991) 4.36

Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist (2000) 4.24

Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry (2001) 3.66

Cloning and expression of a rat D2 dopamine receptor cDNA. Nature (1989) 3.59

Isolation of cDNA clones coding for the beta subunit of human beta-hexosaminidase. Proc Natl Acad Sci U S A (1985) 3.50

Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem (2000) 3.22

Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science (1975) 3.12

Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08

Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89

Brain dopamine receptors. Pharmacol Rev (1980) 2.88

Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85

The displacement of membrane calcium by a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 2.83

Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem (1986) 2.54

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41

Transient holes in the erythrocyte membrane during hypotonic hemolysis and stable holes in the membrane after lysis by saponin and lysolecithin. J Cell Biol (1967) 2.40

Membrane formation by the adenosine triphosphatase of sarcoplasmic reticulum. J Biol Chem (1971) 2.34

Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology (1996) 2.18

The proton relaxation of benzyl alcohol in erythrocyte membranes. Mol Pharmacol (1968) 2.17

Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A (1975) 2.16

Characterization of apelin, the ligand for the APJ receptor. J Neurochem (2000) 2.11

Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem (1989) 2.10

Dopamine D4 receptors elevated in schizophrenia. Nature (1993) 2.09

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet (1993) 2.09

Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. J Biol Chem (1999) 2.05

Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride. J Neurochem (1995) 2.03

The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do not. Biochim Biophys Acta (1972) 2.02

Discovery of a receptor related to the galanin receptors. FEBS Lett (1999) 2.01

Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature (1988) 1.88

The membrane concentration of a local anesthetic (chlorpromazine). Biochim Biophys Acta (1969) 1.86

Dopamine receptor pharmacology. Trends Pharmacol Sci (1994) 1.85

Anti-schizophrenic drugs--membrane receptor sites of action. Biochem Pharmacol (1977) 1.85

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry (2000) 1.71

The dopamine D(4) receptor: one decade of research. Eur J Pharmacol (2000) 1.69

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res (1999) 1.68

Cloning and expression of human and rat D1 dopamine receptors. Nature (1990) 1.65

Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed Proc (1974) 1.64

Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J Biol Chem (2000) 1.63

The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav (2006) 1.63

Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem (1990) 1.63

Discovery and mapping of ten novel G protein-coupled receptor genes. Gene (2001) 1.60

D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1991) 1.55

Dopamine receptor genes: new tools for molecular psychiatry. J Psychiatry Neurosci (1992) 1.53

Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature (1978) 1.52

Discovery of three novel G-protein-coupled receptor genes. Genomics (1998) 1.50

A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem Biophys Res Commun (1997) 1.50

Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem (1989) 1.45

Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry (2001) 1.42

Discovery of a novel member of the histamine receptor family. Mol Pharmacol (2001) 1.41

Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J Biol Chem (1995) 1.39

Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol (2000) 1.37

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol (1982) 1.36

Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci (2000) 1.35

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry (2002) 1.33

Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol (2001) 1.32

Calcium reversal of nerve blockade by alcohols, anesthetics, tranquilizers, and barbiturates. Can J Physiol Pharmacol (1974) 1.31

Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse (2000) 1.31

Membrane expansion of the erythrocyte by both the neutral and ionized forms of chlorpromazine. Biochim Biophys Acta (1969) 1.29

The site of action of caffeine and procaine in skeletal muscle. J Pharmacol Exp Ther (1971) 1.29

Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science (1984) 1.28

New detection of brain dopamine receptors with (3H)dihydroergocryptine. Proc Natl Acad Sci U S A (1977) 1.28

Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol (1999) 1.27

The membrane concentrations of alcohol anesthetics. Biochim Biophys Acta (1971) 1.27

Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long-Evans rat. Food Chem Toxicol (1998) 1.26

Cloning of human genes encoding novel G protein-coupled receptors. Genomics (1994) 1.26

A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature (1992) 1.26

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) (2000) 1.25

Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25

Quantitation of vasopressin mRNA and oxytocin mRNA in hypothalamic nuclei by solution hybridization assays. J Neurochem (1986) 1.22

Structure of membrane holes in osmotic and saponin hemolysis. J Cell Biol (1973) 1.21

FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun (2001) 1.20

Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. Proc Natl Acad Sci U S A (1976) 1.20

Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol (1994) 1.20

Membrane expansion of intact erythrocytes by anesthetics. Biochim Biophys Acta (1969) 1.19

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature (1978) 1.19

Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun (1996) 1.18

Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). J Biol Chem (1986) 1.18

Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun (1993) 1.17

Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci U S A (1989) 1.17

Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics (1999) 1.16

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother (2000) 1.16

Molecular biology of the dopamine receptors. Eur J Pharmacol (1991) 1.14

The effect of membrane-strain rate and of temperature on erythrocyte fragility and critical hemolytic volume. Biochim Biophys Acta (1969) 1.14

Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience (1997) 1.14

Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol (1998) 1.14

Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol (1994) 1.14

Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature (1978) 1.13

Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. Proc Natl Acad Sci U S A (1981) 1.12

Multiple receptors for brain dopamine. Proc Natl Acad Sci U S A (1978) 1.11

Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res (2001) 1.10

The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology (1985) 1.10

Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology. Trends Pharmacol Sci (1999) 1.10

Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration. Mol Pharmacol (1991) 1.09

Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry (1993) 1.09